Butadiene telomerization catalyst preparation and use thereof

US11713286B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11713286-B2
Application numberUS-202217703458-A
CountryUS
Kind codeB2
Filing dateMar 24, 2022
Priority dateApr 10, 2015
Publication dateAug 1, 2023
Grant dateAug 1, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Catalyst compositions are prepared by contacting a palladium source and 1,3,5,7-tetramethyl-6-(2,4-dimethoxyphenyl)-2,4,8-trioxa-6-phosphaadamantane and a methoxyocta-diene compound, in a primary aliphatic alcohol, under suitable conditions including a ratio of equivalents of palladium to equivalents of 1,3,5,7-tetramethyl-6-(2,4-dimethoxyphenyl)-2,4,8-trioxa-6-phosphaadamantane ranging from greater than 1:1 to 1:1.3. The result is a complex of palladium, a 1,3,5,7-tetramethyl-6-(2,4-dimethoxyphenyl)-2,4,8-trioxa-6-phosphaada-mantane ligand, and a ligand selected from a methoxyoctadiene ligand, an octadienyl ligand, or a protonated octadienyl. Such complexes may, in solution, exhibit surprising solubility and storage stability and are useful in the telomerization of butadiene, which is a step in the production of 1-octene.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for preparing a catalyst composition useful for catalyzing the telomerization of butadiene comprising dissolving as reagents a palladium source, 1,3,5,7-tetramethyl-6-(2,4-dimethoxyphenyl)-2,4,8-trioxa-6-phosphaadamantane, as set forth in structures (I) and (II), and a methoxyoctadiene compound in a primary aliphatic alcohol, such that the ratio of equivalents of the palladium to equivalents of the 1,3,5,7-tetramethyl-6-(2,4-dimethoxyphenyl)-2,4,8-trioxa-6-phosphaadamantane ranges from greater than 1:1 to 1:1.3, to form a catalyst composition comprising a complex comprising palladium, a 1,3,5,7-tetramethyl-6-(2,4-dimethoxyphenyl)-2,4,8-trioxa-6-phosphaadamantane ligand, and a ligand selected from a methoxyoctadiene ligand, an octadienyl ligand, or a protonated octadienyl ligand, in the primary aliphatic alcohol. 2. The process of claim 1 wherein: (a) the palladium source is selected from palladium acetylacetonate, palladium formate, palladium acetate, palladium propionate, palladium octanoate, palladium carbonate, palladium hydroxide, palladium citrate, tetrakis(triphenylphosphine) palladium, bis(1,5-cyclooctadiene) palladium, bis(dibenzylideneacetone) palladium, and combinations thereof; (b) the methoxyoctadiene compound is selected from 1-methoxy-2,7-octadiene, 3-methoxy-1,7-octadiene, and combinations thereof; (c) the primary aliphatic alcohol is selected from methanol, ethanol, propanol, butanol, ethylene glycol, propylene glycol, glycerol, and combinations thereof; or (d) a combination thereof. 3. The process of claim 1 , wherein the palladium source is selected from palladium acetylacetonate, palladium formate, palladium acetate, palladium propionate, palladium octanoate, palladium carbonate, palladium hydroxide, palladium citrate, tetrakis(triphenylphosphine) palladium, bis(1,5-cyclooctadiene) palladium, bis(dibenzylideneacetone) palladium, and combinations thereof. 4. The process of claim 1 , wherein the methoxyoctadiene compound is selected from 1-methoxy-2,7-octadiene, 3-methoxy-1,7-octadiene, and combinations thereof. 5. The process of claim 1 , wherein the primary aliphatic alcohol is selected from methanol, ethanol, propanol, butanol, ethylene glycol, propylene glycol, glycerol, and combinations thereof. 6. The process of claim 1 , wherein the process further comprises adding (a) a carboxylic acid; (b) a promoter selected from alkoxides, enolates, phenoxides, borohydrides, and hydrazides, all of alkali metals; alkaline earth metals and quaternary ammoniums; alkali metal salts; or a combination thereof; or (c) a combination thereof. 7. The process of claim 1 , wherein the process further comprises adding a carboxylic acid. 8. The process of claim 1 , wherein the process further comprises adding a promoter. 9. The process of claim 8 , wherein the promoter is selected from alkoxides, enolates, phenoxides, borohydrides, and hydrazides, all of alkali metals; alkaline earth metals and quaternary ammoniums; alkali metal salts; or a combination thereof. 10. The process of claim 1 , wherein the ratio of equivalents of the palladium source to the equivalents of the 1,3,5,7-tetramethyl-6-(2,4-dimethoxyphenyl)-2,4,8-trioxa-6-phospha-adamantane ranges from 1:1.2 to 1:1.3.

Assignees

Inventors

Classifications

  • C07C2/406Primary

    with hydrides or organic compounds · CPC title

  • and further hetero atoms as ring members, excluding the positions adjacent to P · CPC title

  • C07C41/06Primary

    by addition of organic compounds only · CPC title

  • Olefin oligomerisation or telomerisation · CPC title

  • Palladium · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11713286B2 cover?
Catalyst compositions are prepared by contacting a palladium source and 1,3,5,7-tetramethyl-6-(2,4-dimethoxyphenyl)-2,4,8-trioxa-6-phosphaadamantane and a methoxyocta-diene compound, in a primary aliphatic alcohol, under suitable conditions including a ratio of equivalents of palladium to equivalents of 1,3,5,7-tetramethyl-6-(2,4-dimethoxyphenyl)-2,4,8-trioxa-6-phosphaadamantane ranging from gr…
Who is the assignee on this patent?
Dow Global Technologies Llc
What technology area does this patent fall under?
Primary CPC classification C07C2/406. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).